The changes in acute-phase proteins can certainly be seen as reflecting immune responses to the viral infection, with the interleukin (IL)-6 cytokine family representing the statistically most significantly enriched upstream regulators among acute-phase proteins identified as altered in the context of COVID-19. The gene discussed is IL6; the disease is COVID-19.